相关实验视频
Updated: Jan 17, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.2K
甲状腺癌:从分子洞察到治疗 (评论)
Zhuozheng Li1, Nuofan Wang2, Xiao Li3
1School of Life Science and Technology, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China.
Oncology letters
|September 22, 2025
概括
这篇评论详细介绍了甲状腺癌亚型,重点关注像BRAF V600E突变和非编码RNAs这样的分子驱动因素. 它强调了诊断进步和亚型特定疗法,以改善甲状腺瘤学的结果.
科学领域:
- 内分泌学和瘤学的内分泌学和瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 甲状腺癌是一个日益严重的全球健康问题,有不同的亚型.
- 每个亚型 (PTC,FTC,MTC,ATC) 都具有独特的分子驱动因素和信号通路失调.
- 了解这些分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 为推动不同类型甲状腺癌亚型的分子机制提供全面的概述.
- 审查甲状腺癌诊断工具的最新进展.
- 总结甲状腺癌的新兴和有针对性的治疗策略.
主要方法:
- 对甲状腺癌亚型的分子机制,诊断创新和治疗策略的文献综述.
- 在PTC,FTC,MTC和ATC中分析遗传变化,非编码RNA失调和代谢重编程.
- 检查当前和新型治疗方法,包括向疗法和代谢干预措施.
主要成果:
- 乳头甲状腺癌 (PTC) 是由BRAF V600E和非编码RNA驱动的,激活MAPK信号并表现出代谢变化.
- 毛囊性甲状腺癌 (FTC) 涉及Ras突变,改变脂质代谢和PI3K/AKT激活.
- 状甲状腺癌 (MTC) 与RET突变和PD-1/PD-L1通路有关,而状甲状腺癌 (ATC) 则具有侵略性的基因变异和侵入性.
- 创新包括血清生物标志物 (例如,斯坦尼奥卡尔-1,miR-26b-5p),放射学和用于诊断的光学成像.
- 有针对性的疗法 (vemurafenib,sorafenib,vandetanib) 和代谢干预 (metformin) 是有前途的.
结论:
- 甲状腺癌亚型表现出明显的分子形状,这决定了它们的进展和对治疗的反应.
- 特定亚型的诊断和治疗方法对于改善患者的治疗结果至关重要.
- 对分子机制和新疗法的持续研究对于推进甲状腺癌治疗至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

